The burden of skin disease: quality of life, economic aspects and social issues.

Suppr

超能文献

作者信息

Finlay Andrew Y

机构信息

School of Medicine, Cardiff University.

出版信息

Clin Med (Lond). 2009 Dec;9(6):592-4. doi: 10.7861/clinmedicine.9-6-592.

DOI:10.7861/clinmedicine.9-6-592

PMID:20095308

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4952304/

Abstract

摘要

相似文献

The burden of skin disease: quality of life, economic aspects and social issues.

Clin Med (Lond). 2009 Dec;9(6):592-4. doi: 10.7861/clinmedicine.9-6-592.

A catalog of dermatology utilities: a measure of the burden of skin diseases.

J Investig Dermatol Symp Proc. 2004 Mar;9(2):160-8. doi: 10.1046/j.1087-0024.2003.09112.x.

Quality of life - an essential parameter for dermatology.

J Eur Acad Dermatol Venereol. 2017 Apr;31(4):573. doi: 10.1111/jdv.14184.

Dermatology quality of life instruments: sorting out the quagmire.

J Invest Dermatol. 2007 Dec;127(12):2695-6. doi: 10.1038/sj.jid.5701176.

The Role of Therapy in Impairing Quality of Life in Dermatological Patients: A Multinational Study.

Acta Derm Venereol. 2018 Jun 8;98(6):563-569. doi: 10.2340/00015555-2918.

Highlights from the report of the working group on "Core measures of the burden of skin diseases".

J Invest Dermatol. 2007 Dec;127(12):2701-6. doi: 10.1038/sj.jid.5701174.

The psychological impact of living with skin disease.

Prof Nurse. 2003 Aug;18(12):689.

[Assessment of quality of life in dermatology].

J Dtsch Dermatol Ges. 2004 Sep;2(9):802-6. doi: 10.1046/j.1439-0353.2004.04505.x.

Burden of skin disease.

J Am Acad Dermatol. 2007 Apr;56(4):706. doi: 10.1016/j.jaad.2006.09.008.

[A new psycho-dermatology clinic in Israel: our first year experience].

Harefuah. 2011 Jan;150(1):9-12, 70.

引用本文的文献

Assessing the burden of dermatological diseases on work life from a gender perspective.

Sci Rep. 2025 Jul 5;15(1):24014. doi: 10.1038/s41598-025-07804-x.

The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trials.

Nat Commun. 2024 Oct 25;15(1):9230. doi: 10.1038/s41467-024-53384-1.

Quality of life of dermatology outpatients and its associated factors in Halibet National Referral Hospital in Asmara, Eritrea.

Sci Rep. 2024 Jul 15;14(1):16272. doi: 10.1038/s41598-024-67224-1.

The prevalence of comorbid mental health difficulties in young people with chronic skin conditions: A systematic review and meta-analysis.

J Health Psychol. 2025 Mar;30(4):652-679. doi: 10.1177/13591053241252216. Epub 2024 May 29.

Beyond Allergies-Updates on The Role of Mas-Related G-Protein-Coupled Receptor X2 in Chronic Urticaria and Atopic Dermatitis.

Cells. 2024 Jan 25;13(3):220. doi: 10.3390/cells13030220.

Lipid Nanoparticle-Mediated Hit-and-Run Approaches Yield Efficient and Safe Gene Editing in Human Skin.

ACS Nano. 2023 Nov 14;17(21):22046-22059. doi: 10.1021/acsnano.3c08644. Epub 2023 Nov 2.

RSDB: A rare skin disease database to link drugs with potential drug targets for rare skin diseases.

Sci Data. 2022 Aug 26;9(1):521. doi: 10.1038/s41597-022-01654-2.

Role of betamethasone valerate 2.250 mg medicated plaster in the treatment of psoriasis and other dermatological pathologies: a review.

Drugs Context. 2018 Aug 20;7:212539. doi: 10.7573/dic.212539. eCollection 2018.

Protein-Trap Insertional Mutagenesis Uncovers New Genes Involved in Zebrafish Skin Development, Including a Neuregulin 2a-Based ErbB Signaling Pathway Required during Median Fin Fold Morphogenesis.

PLoS One. 2015 Jun 25;10(6):e0130688. doi: 10.1371/journal.pone.0130688. eCollection 2015.

本文引用的文献

The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results.

Br J Dermatol. 2008 Nov;159(5):997-1035. doi: 10.1111/j.1365-2133.2008.08832.x. Epub 2008 Sep 15.

The socioeconomic impact of atopic dermatitis in the United States: a systematic review.

Pediatr Dermatol. 2008 Jan-Feb;25(1):1-6. doi: 10.1111/j.1525-1470.2007.00572.x.

The pharmacoeconomics of acne treatment: where are we heading?

J Dermatolog Treat. 2008;19(1):27-37. doi: 10.1080/09546630701729895.

Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients.

Arch Dermatol. 2008 Jan;144(1):35-9. doi: 10.1001/archdermatol.2007.5.

Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population-based study.

Br J Dermatol. 2008 Feb;158(2):351-9. doi: 10.1111/j.1365-2133.2007.08354.x. Epub 2007 Dec 6.

Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients.

J Invest Dermatol. 2007 Oct;127(10):2315-22. doi: 10.1038/sj.jid.5700875. Epub 2007 May 10.

The family impact of skin diseases: the Greater Patient concept.

Br J Dermatol. 2007 May;156(5):929-37. doi: 10.1111/j.1365-2133.2007.07794.x. Epub 2007 Mar 23.

The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology.

J Am Acad Dermatol. 2006 Sep;55(3):490-500. doi: 10.1016/j.jaad.2006.05.048.

Translating the science of quality of life into practice: What do dermatology life quality index scores mean?

J Invest Dermatol. 2005 Oct;125(4):659-64. doi: 10.1111/j.0022-202X.2005.23621.x.

British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005.

Br J Dermatol. 2005 Sep;153(3):486-97. doi: 10.1111/j.1365-2133.2005.06893.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验